Targeting BCL‐2 family proteins to overcome drug resistance in non‐small cell lung cancer

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Cancer

• Publication date

  2007-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.22977PMID 17688235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

  2007cited by this paper
• Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.

  2007cited by this paper
• Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak

  2007influential reference
• Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

  2006cited by this paper
• A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo.

  2006cited by this paper
• Therapeutic targeting of apoptotic pathways in cancer.

  2006cited by this paper
• The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

  2006cited by this paper
• Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.

  2005influential reference
• BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.

  2005cited by this paper
• Erlotinib in previously treated non-small-cell lung cancer.

  2005cited by this paper
• An inhibitor of Bcl-2 family proteins induces regression of solid tumours

  2005influential reference
• Apoptotic pathways: ten minutes to dead.

  2005cited by this paper
• Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

  2005cited by this paper
• Inaugural Article: Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1

  2005cited by this paper
• The Pathophysiology of Mitochondrial Cell Death

  2004cited by this paper
• Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation

  2004cited by this paper
• Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix

  2004cited by this paper
• Cell-cycle checkpoints and cancer

  2004cited by this paper
• Alterations in the apoptotic machinery and their potential role in anticancer drug resistance

  2003cited by this paper
• p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation

  2003cited by this paper
• Apoptosis A Link between Cancer Genetics and Chemotherapy

  2002cited by this paper
• The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines

  2002cited by this paper
• The Bcl2 family: regulators of the cellular life-or-death switch

  2002cited by this paper
• Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

  2002cited by this paper
• Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

  2002cited by this paper
• Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

  2001cited by this paper
• Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

  2001cited by this paper
• BAX-dependent transport of cytochrome c reconstituted in pure liposomes

  2000cited by this paper
• Apoptotic Protease Activating Factor 1 (Apaf-1)–Independent Cell Death Suppression by Bcl-2

  2000cited by this paper
• The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues.

  2000cited by this paper
• p53 Induces Apoptosis by Caspase Activation through Mitochondrial Cytochrome c Release*

  2000cited by this paper
• Genetic analysis of chemoresistance in primary murine lymphomas

  2000cited by this paper
• Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity.

  2000cited by this paper
• Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

  1997cited by this paper
• DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2.

  1994cited by this paper
• [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

  1987cited by this paper

• BCL-2 and BCL-xL in Cancer: Regulation, Function, and Therapeutic Targeting

  2026cites this paper
• Obatoclax enhances TRAIL-induced apoptosis in non-small-cell-lung-cancer cells by increasing TRAIL receptor expression, priming for mitochondrial apoptosis and reducing XIAP levels

  2025cites this paper
• Polyphenolic dendrimers as carriers of anticancer siRNA.

  2024cites this paper
• Targeted intracellular delivery of BH3 mimetic peptide inhibits BCL-2 activity and prevents breast cancer development

  2024cites this paper
• Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy

  2023cites this paper
• Engineered Celastrol and Plasmid Co-Delivery for in situ Expression and Targeted Mitochondrial Relocation of Nur77 Protein towards Effective Drug Resistance Reversion

  2022cites this paper
• Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy

  2022cites this paper
• Structural revision of the Mcl-1 inhibitor MIM1: synthesis and biological studies on ovarian cancer cells with evaluation of designed analogues.

  2021cites this paper
• Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux

  2021cites this paper
• Chimeric siRNA-DNA Surfactants for the Enhanced Delivery and Sustained Cytotoxicity of a Gold(III) Metallodrug.

  2020cites this paper
• Cell-Permeable Bak BH3 Peptide Induces Chemosensitization of Hematologic Malignant Cells

  2020cites this paper
• Targeting Bcl-2 Family Proteins: What, Where, When?

  2020cites this paper
• A review on RNAi therapy for NSCLC: Opportunities and challenges.

  2020cites this paper
• Targeted drug therapy in non-small cell lung cancer: Clinical significance and possible solutions-Part I

  2020cites this paper
• Retraction Retracted: Apoptosis and Molecular Targeting Therapy in Cancer

  2020cites this paper
• MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically

  2020cites this paper
• Antioxidant and Antiproliferative Activity of Selected Medicinal Plants of Lower Assam, India: An In Vitro and In Silico Study.

  2020cites this paper
• Absence of HTATIP2 Expression in A549 Lung Adenocarcinoma Cells Promotes Tumor Plasticity in Response to Hypoxic Stress

  2020influential citation
• Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy.

  2020cites this paper
• Disruption of conserved polar interactions causes a sequential release of Bim mutants from the canonical binding groove of Mcl1.

  2020cites this paper
• Structure–Activity Relationships and Molecular Docking Analysis of Mcl-1 Targeting Renieramycin T Analogues in Patient-derived Lung Cancer Cells

  2020cites this paper
• Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer

  2020cites this paper
• Saga of Mcl-1: regulation from transcription to degradation

  2020cites this paper
• 5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis

  2019cites this paper
• Live Attenuated Salmonella enterica Expressing and Releasing Cell-Permeable Bax BH3 Peptide Through the MisL Autotransporter System Elicits Antitumor Activity in a Murine Xenograft Model of Human B Non-hodgkin's Lymphoma

  2019cites this paper
• A perspective profile of ADCY1 in cAMP signaling with drug-resistance in lung cancer

  2019cites this paper
• Jorunnamycin A from Xestospongia sp. Suppresses Epithelial to Mesenchymal Transition and Sensitizes Anoikis in Human Lung Cancer Cells.

  2019cites this paper
• Lumichrome Inhibits Human Lung Cancer Cell Growth and Induces Apoptosis via a p53-Dependent Mechanism

  2019cites this paper
• Investigating the Molecular Basis of N-Substituted 1-Hydroxy-4-Sulfamoyl-2-Naphthoate Compounds Binding to Mcl1

  2019cites this paper
• A bibenzyl from Dendrobium ellipsophyllum induces apoptosis in human lung cancer cells

  2018cites this paper
• Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

  2018cites this paper
• Assessment of the impact of deregulated signal transduction pathways on the radiotherapy response of non-small-cell lung cancer

  2018cites this paper
• Unraveling the molecular mechanism of benzothiophene and benzofuran scaffold-merged compounds binding to anti-apoptotic Myeloid cell leukemia 1

  2018cites this paper
• Peptides extracted from edible mushroom: Lentinus squarrosulus induces apoptosis in human lung cancer cells

  2017cites this paper
• FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradation

  2017cites this paper
• Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells

  2017cites this paper
• Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.

  2017cites this paper
• Bishydroquinone Renieramycin M Induces Apoptosis of Human Lung Cancer Cells Through a Mitochondria-dependent Pathway.

  2016cites this paper
• New Frontiers in Cancer Chemotherapy — Targeting Cell Death Pathways

  2016cites this paper
• Targeting Gb3 and apoptosis- related proteins to overcome cisplatin resistance

  2016cites this paper
• Toward chelerythrine optimization: Analogues designed by molecular simplification exhibit selective growth inhibition in non-small-cell lung cancer cells.

  2016cites this paper
• Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers.

  2015cites this paper
• First evidence that oligopyridines, α-helix foldamers, inhibit Mcl-1 and sensitize ovarian carcinoma cells to Bcl-xL-targeting strategies.

  2015cites this paper
• Klinikum rechts der Isar Inhibition of MCL-1 blocks the development of KRAS-driven adenocarcinoma of the lung Enkhtsetseg Munkhbaatar

  2015influential citation
• Let-7b binding site polymorphism in the B-cell lymphoma-extra large 3'UTR is associated with fluorouracil resistance of hepatocellular carcinoma.

  2015cites this paper
• Autophagy inhibition enhances pan-Bcl-2 inhibitor AT-101-induced apoptosis in non-small cell lung cancer.

  2014influential citation
• Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer

  2014cites this paper
• Apoptosis and Molecular Targeting Therapy in Cancer

  2014cites this paper
• Caffeine inhibits paclitaxel‑induced apoptosis in colorectal cancer cells through the upregulation of Mcl‑1 levels.

  2014cites this paper
• Sabutoclax ( BI 97 C 1 ) and BI 112 D 1 , Putative Inhibitors of MCL-1 , Induce Mitochondrial Fragmentation Either Upstream of or Independent of Apoptosis 1 , 2

  2014cites this paper
• A study of the structural properties and thermal stability of human Bcl-2 by molecular dynamics simulations

  2014cites this paper
• Pien Tze Huang induces apoptosis in multidrug‑resistant U2OS/ADM cells via downregulation of Bcl‑2, survivin and P-gp and upregulation of Bax.

  2014cites this paper
• LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells

  2014cites this paper
• Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.

  2014cites this paper
• The role of mitochondria in the development and progression of lung cancer

  2013cites this paper
• Sabutoclax (BI97C1) and BI112D1, putative inhibitors of MCL-1, induce mitochondrial fragmentation either upstream of or independent of apoptosis.

  2013cites this paper
• lymphoma to Rituximab-induced apoptosis Targeting Bcl-2 family proteins modulates the sensitivity of B-cell

  2013cites this paper
• BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins.

  2013cites this paper
• PI3K inhibition potentiates Bcl-2-dependent apoptosis in renal carcinoma cells

  2013cites this paper
• Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade

  2013cites this paper
• Chemical perturbation of Mcl-1 pre-mRNA splicing to induce apoptosis in cancer cells.

  2013cites this paper
• Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis

  2013cites this paper
• Targeting apoptosis pathways in lung cancer.

  2013cites this paper
• Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.

  2013cites this paper
• Long-term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells

  2012cites this paper
• Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies

  2012cites this paper
• Anti-cancer drug discovery and development

  2012cites this paper
• Computational modeling and simulation of the Bcl-2 family: paving the way for rational drug design.

  2012cites this paper
• Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.

  2012cites this paper
• ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib.

  2012cites this paper
• Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer

  2012cites this paper
• Biomarkers of Therapeutic Response to BCL2 Antagonists in Cancer

  2012cites this paper
• Expression of Bim, Noxa, and Puma in non-small cell lung cancer

  2012cites this paper
• Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad

  2012cites this paper
• An Optically Pure Apogossypolone Derivative as Potent Pan-Active Inhibitor of Anti-Apoptotic Bcl-2 Family Proteins

  2011cites this paper
• Synergistic killing of colorectal cancer cells by oxaliplatin and ABT-737

  2011cites this paper
• Microtubule-targeted agents: when mitochondria become essential to chemotherapy.

  2011cites this paper
• Anti-tumor pyrimidinylpiperazines bind to the prosurvival Bcl-2 protein family member Bcl-XL.

  2011cites this paper
• Molecular and Cellular Pathobiology Interaction between MYC and MCL 1 in the Genesis and Outcome of Non – Small-Cell Lung Cancer

  2011cites this paper
• Preclinical Development Synergistic Antitumor Activity of Gemcitabine and ABT-737 In Vitro and In Vivo through Disrupting the Interaction of USP 9 X and Mcl-1

  2011cites this paper
• Contrôle de la signalisation oncogénique du mutant L858R de l'EGFR par la protéine suppresseur de tumeur p14ARF dans les adénocarcinomes pulmonaires

  2011cites this paper
• Apoptosis: Physiology and Pathology

  2011cites this paper
• Contrôle de la signalisation oncogénique du mutant L858R de l'EGFR par la protéine

  2011cites this paper
• Modification of Bcl-x and Mcl-1 pre-mRNA splicing using splice-switching oligonucleotides

  2011cites this paper
• Functional and Clinical Characterization of the Putative Tumor Suppressor WWOX in Non-small Cell Lung Cancer

  2011cites this paper
• Synergistic Antitumor Activity of Gemcitabine and ABT-737 In Vitro and In Vivo through Disrupting the Interaction of USP9X and Mcl-1

  2011cites this paper
• Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma

  2011cites this paper
• Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines

  2011cites this paper
• Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

  2010cites this paper
• Actinomycin D synergistically enhances the efficacy of the BH3 mimetic ABT-737 by downregulating Mcl-1 expression

  2010cites this paper
• TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives.

  2010cites this paper
• Evaluation of PTEN and Mcl-1 expressions in NSCLC expressing wild-type or mutated EGFR

  2010cites this paper
• Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway

  2010cites this paper
• BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.

  2010cites this paper
• Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.

  2010cites this paper
• ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer

  2010cites this paper
• ERBB 2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer

  2010cites this paper
• Lung Cancer Resistance to Chemotherapy

  2010cites this paper
• Oxidative Stress and Drug Resistance in Cancer

  2009cites this paper
• Combined Bcl-2/Mammalian Target of Rapamycin Inhibition Leads to Enhanced Radiosensitization via Induction of Apoptosis and Autophagy in Non–Small Cell Lung Tumor Xenograft Model

  2009cites this paper